Search results for "Cardiometabolic risk"

showing 10 items of 42 documents

Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities.

2019

BACKGROUND: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients. MATERIALS AND METHODS: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) b…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesHemodynamics030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineWaist–hip ratioobesity cardiac structureInternal medicinemedicineHumansCardiac structure030212 general & internal medicineObesityPhenomicsskin and connective tissue diseasesCorrelation of DataEchocardiography Doppler PulsedAdiponectinbusiness.industryCardiometabolic Risk FactorsStroke VolumeGeneral MedicineOrgan SizeMiddle Agedmedicine.diseaseObesityBlood pressureItalyEchocardiographycardiovascular systemCardiologyFemaleHypertrophy Left Ventricularsense organsAdiponectinCardiology and Cardiovascular MedicinebusinessFunction (biology)Acta cardiologica
researchProduct

Longitudinal associations of physical activity and sedentary time with cardiometabolic risk factors in children

2018

BACKGROUND There are few prospective studies on the associations of changes in objectively measured vigorous physical activity (VPA∆ ), moderate-to-vigorous physical activity (MVPA∆ ), light physical activity (LPA∆ ), and sedentary time (ST∆ ) with changes in cardiometabolic risk factors (∆ ) in children. We therefore investigated these relationships among children. METHODS The participants were a population sample of 258 children aged 6-8 years followed for 2 years. We assessed PA and ST by a combined heart rate and movement sensor; computed continuous age- and sex-adjusted z-scores for waist circumference, blood pressure, and fasting insulin, glucose, triglycerides, and high-density lipop…

Blood GlucoseMaleCross-sectional studyphysical activityBlood Pressureliikunta030204 cardiovascular system & hematologyBody fat percentagechemistry.chemical_compound0302 clinical medicineHeart RateRisk FactorsInsulinOrthopedics and Sports MedicineLongitudinal StudiesProspective StudiesChildta315Prospective cohort studyFinlandAnthropometryriskitekijätLipidsCardiovascular DiseasesFemalelipids (amino acids peptides and proteins)Waist Circumferencefyysinen aktiivisuusmedicine.medical_specialtyWaistPhysical Therapy Sports Therapy and Rehabilitationpitkittäistutkimusta3111Article03 medical and health sciencesMetabolic DiseaseschildrenInternal medicineHeart ratemedicineHumansExerciselapsetCholesterolbusiness.industryterveydentila030229 sport sciencesAnthropometrycardiometabolic risk factorsCross-Sectional StudiesBlood pressurechemistrySedentary BehaviorbusinessScandinavian Journal of Medicine & Science in Sports
researchProduct

Longitudinal associations of physical activity and sedentary time with cardiometabolic risk factors in children

2019

Background: There are few prospective studies on the associations of changes in objectively measured vigorous physical activity (VPA∆), moderate‐to‐vigorous physical activity (MVPA∆), light physical activity (LPA∆), and sedentary time (ST∆) with changes in cardiometabolic risk factors (∆) in children. We therefore investigated these relationships among children. Methods: The participants were a population sample of 258 children aged 6‐8 years followed for 2 years. We assessed PA and ST by a combined heart rate and movement sensor; computed continuous age‐ and sex‐adjusted z‐scores for waist circumference, blood pressure, and fasting insulin, glucose, triglycerides, and high‐density lipoprot…

childrenterveydentilaphysical activitylipids (amino acids peptides and proteins)riskitekijätpitkittäistutkimusliikuntacardiometabolic risk factorslapsetfyysinen aktiivisuus
researchProduct

Accuracy of different cutoffs of the waist‐to‐height ratio as a screening tool for cardiometabolic risk in children and adolescents: A systematic rev…

2021

The present systematic review with meta-analysis sought to estimate the accuracy of different waist-to-height ratio (WHtR) cutoff ranges as risk indicators for cardiometabolic health in different populations of children and adolescents. Systematic searches were undertaken to identify studies in apparently healthy participants aged 3–18 years that conducted receiver operating characteristic curve analysis and reported area under the receiver operating characteristic curves for WHtR with any cardiometabolic biomarker. Forty-one cross-sectional studies were included in the meta-analysis, including 138,561 young individuals (50% girls). Higher area under summary receiver operating characteristi…

Maleanthropometric indexreceiver-operating characteristic curveAdolescentEndocrinology Diabetes and MetabolismSoutheast asianmetabolic syndromeBody Mass IndexRisk FactorsHumansMedicineCutoffScreening toolChildMetabolic SyndromeCardiometabolic riskWaist-to-height ratioWaist-Height RatioReceiver operating characteristicDiagnostic Tests Routinebusiness.industryPublic Health Environmental and Occupational HealthDiagnostic testCross-Sectional Studiesdiagnostic testCardiovascular DiseasesChild PreschoolMeta-analysisFemaleWaist CircumferencebusinessDemographyObesity Reviews
researchProduct

Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us

2022

As the world enters its third year of the COVID-19 pandemic, individuals with diabetes have faced particular challenges from the virus. A deleterious bidirectional relationship exists between the two disorders, with heightened inflammatory, immunologic, and cellular mechanisms leading to a more severe illness and increased morbidity and mortality. Tight glucose control, though necessary, is hampered by physical restrictions and difficulty accessing health care. Novel glucose-lowering medications may provide unique benefits in this regard. It is imperative that multi-pronged efforts be prioritized in order to reduce adverse outcomes in patients with diabetes at risk for COVID-19.

GlucoseCOVID-19 cardiometabolic risk complications diabetes obesity treatmentSARS-CoV-2Endocrinology Diabetes and MetabolismDiabetes MellitusInternal MedicineCOVID-19HumansPandemicsMetabolic Syndrome and Related Disorders
researchProduct

Blood cell transcript levels in 5-year-old children as potential markers of breastfeeding effects in those small for gestational age at birth

2019

BackgroundNutrition of the newborn during the early postnatal period seems to be of capital importance and there is clinical evidence showing the protective effect of breastfeeding compared with formula feeding on childhood obesity and its comorbidities. Infants born small for gestation age may be more sensitive to the type of feeding during lactation. Here, we aimed to analyze the impact of birth weight and the type of infant feeding on the expression levels in peripheral blood cells of selected candidate genes involved in energy homeostasis in 5-year-old children, to find out potential early biomarkers of metabolic programming effects during this period of metabolic plasticity.MethodsFort…

Male0301 basic medicinehumanosBreastfeedingPhysiologylcsh:MedicineSangBlood Pressureregulación de la expresión génicalactancia materna0302 clinical medicineLactationBirth Weightcélulas sanguíneasGeneral MedicineARNmedicine.anatomical_structureBreast FeedingChild Preschool030220 oncology & carcinogenesisInfant Small for Gestational AgeInfant formulaGestationFemaleInfantspresión sanguíneaBreast milkSystoleBirth weightBreast milkGeneral Biochemistry Genetics and Molecular BiologyChildhood obesity03 medical and health sciencessístoleMetabolic programmingmedicineHumansRNA Messengerpeso al nacerlactanteBlood Cellsbusiness.industryResearchlcsh:RInfant NewbornInfantmedicine.diseaseCardiometabolic risk factors030104 developmental biologyInfant formulaGene Expression RegulationSmall for gestational ageRNAbusinessBiomarkers
researchProduct

Developmental and Early Life Origins of Cardiometabolic Risk Factors

2021

The intent of this review is to critically consider the data that support the concept of programming and its implications. Birth weight and growth trajectories during childhood are associated with cardiometabolic disease in adult life. Both extremes, low and high birth weight coupled with postnatal growth increase the early presence of cardiometabolic risk factors and vascular imprinting, crucial elements of this framework. Data coming from epigenetics, proteomics, metabolomics, and microbiota added relevant information and contribute to better understanding of mechanisms as well as development of biomarkers helping to move forward to take actions. Research has reached a stage in which suff…

AdultEpigenomicsMaleProteomicsGerontologyAgingAdolescentBirth weightGestational Age030204 cardiovascular system & hematologyCardiovascular SystemEpigenesis Genetic03 medical and health sciences0302 clinical medicineMetabolic DiseasesAdverse Childhood ExperiencesPregnancyRisk FactorsInternal MedicineBirth WeightHumansMetabolomics030212 general & internal medicinePrecision MedicinePostnatal growthChildImprinting (organizational theory)High birth weightCardiometabolic riskMicrobiotaInfant NewbornInfantInfant Low Birth WeightMiddle AgedEarly lifeAdult lifeCardiovascular DiseasesChild PreschoolPrenatal Exposure Delayed EffectsFemalePsychologyRelevant informationInfant PrematureForecastingHypertension
researchProduct

The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Li…

2020

Proteins play a crucial role in metabolism, in maintaining fluid and acid-base balance and antibody synthesis. Dietary proteins are important nutrients and are classified into: 1) animal proteins (meat, fish, poultry, eggs and dairy), and, 2) plant proteins (legumes, nuts and soy). Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular (CV) disease (CVD) by attenuating related risk factors. The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat, animal proteins and plant proteins. In view of the available evidence, it has become acceptable to emphasize the …

AdultMaleDietary proteinWeight lossCardiometabolic Risk Factorsfood and beveragesMiddle AgedRecommended Dietary AllowancesCardiovascular diseasePlant Proteins DietaryCardiovascular disease Cholesterol Dietary protein Metabolic syndrome Weight loss Adult Aged Animal Proteins Dietary Cardiometabolic Risk Factors Cardiovascular Diseases Diet Healthy Expert Testimony Female Humans Male Middle Aged Plant Proteins Dietary Young Adult Recommended Dietary AllowancesMetabolic syndromeYoung AdultCholesterolCardiovascular DiseasesAnimal Proteins DietaryHumansFemaleDiet HealthyExpert TestimonyAged
researchProduct

Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study

2018

Purpose: Patients with Cushing’s disease (CD) experience metabolic alterations leading to increased cardiovascular mortality. Recently, the visceral adiposity index (VAI) has been proposed as a marker of visceral adipose tissue dysfunction (ATD) and of the related cardiometabolic risk. We aimed to evaluate the impact of 12-month pasireotide treatment on cardiometabolic risk in CD patients. Methods: This is a multicentre, prospective, and observational study. Sixteen CD patients, referred to the Endocrine Units of the University Hospitals of Messina, Napoli, Padova, and Palermo (Italy), successfully treated with pasireotide for 12 month have been enrolled. In all patients, we assessed anthro…

MaleEndocrinology Diabetes and MetabolismCardiometabolic risk Cushing’s disease hypercortisolism pasireotide visceral adiposity indexLongitudinal StudieDisease030204 cardiovascular system & hematologySettore MED/13 - Endocrinologiachemistry.chemical_compound0302 clinical medicineEndocrinologyRisk FactorsMedicineLongitudinal StudiesProspective StudiesAdiposityFramingham Risk ScoreCushing’s diseaseCushing’s diseaseMiddle AgedPasireotideDiabetes and MetabolismHeart DiseaseItalyAtherosclerosiObesity AbdominalFemaleSomatostatinHumanAdultmedicine.medical_specialtyWaistHeart DiseasesHypercortisolism030209 endocrinology & metabolismIntra-Abdominal Fat03 medical and health sciencesMetabolic DiseasesInternal medicineDiabetes mellitusCardiometabolic risk; Cushing’s disease; Hypercortisolism; Pasireotide; Visceral adiposity index; Endocrinology Diabetes and Metabolism; EndocrinologyHumansPituitary ACTH Hypersecretionbusiness.industryRisk FactorCushing's diseaseAnthropometryAtherosclerosismedicine.diseasePasireotideCardiometabolic riskMetabolic DiseaseVisceral adiposity indexProspective StudiechemistryObservational studybusiness
researchProduct

ETC-1002: A future option for lipid disorders?

2014

ETC-1002 is a new investigational low density lipoprotein cholesterol (LDL-C)-lowering agent (Esperion Therapeutics, Inc.). ETC-1002 is a dicarboxylic acid derivative with a novel mechanism of action targeting two hepatic enzymes - adenosine triphosphate-citrate lyase (ACL) and adenosine monophosphate-activated protein kinase (AMPK), inhibiting sterol and fatty acid synthesis and promoting mitochondrial long-chain fatty acid oxidation. This agent is currently in phase II clinical research. Available data report that ETC-1002 significantly decreased LDL-C levels (up to 32%) in both patients with normal and elevated baseline levels of triglycerides. Such beneficial effect is superior to curre…

Apolipoprotein BLow density lipoprotein cholesterolBlood PressureAMP-Activated Protein Kinaseschemistry.chemical_compoundMiceMulticenter Studies as TopicDicarboxylic AcidsBeta oxidationHypolipidemic AgentsRandomized Controlled Trials as TopicHypolipidemic AgentbiologyFatty AcidsHyperlipidemiaTolerabilityLiverlipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineAMP-Activated Protein Kinasemedicine.drugHumanmedicine.medical_specialtyStatinmedicine.drug_classHypercholesterolemiaHyperlipidemiasClinical Trials Phase II as TopicInternal medicinemedicineAnimalsHumansFatty acid synthesisApolipoproteins BAnimalBody WeightDicarboxylic AcidAMPKCholesterol LDLAdenosineSterolCardiometabolic riskRatsETC-1002Disease Models AnimalEndocrinologychemistrybiology.proteinATP Citrate (pro-S)-LyaseRatFatty AcidLipid lowering therapy
researchProduct